Our results revealed a mechanism by which DAP3 promotes mitochondrial function and HCC progression by regulating MT-ND5 translation and expression, indicating that DAP3 may be a therapeutic target for HCC. The gene discussed is MT-ND5; the disease is hepatocellular carcinoma.